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Abstract
Background: Adults with Down syndrome (DS) are at increased risk for Alzheimer disease dementia, and there is a
pressing need for the development of assessment instruments that differentiate chronic cognitive impairment,
acute neuropsychiatric symptomatology, and dementia in this population of patients.
Methods: We adapted a widely used instrument, the Clinical Dementia Rating (CDR) Scale, which is a component
of the Uniform Data Set used by all federally funded Alzheimer Disease Centers for use in adults with DS, and
tested the instrument among 34 DS patients recruited from the community. The participants were assessed using
two versions of the modified CDR—a caregiver questionnaire and an in-person interview involving both the
caregiver and the DS adult. Assessment also included the Dementia Scale for Down Syndrome (DSDS) and the
Raven’s Progressive Matrices to estimate IQ.
Results: Both modified questionnaire and interview instruments captured a range of cognitive impairments, a
majority of which were found to be chronic when accounting for premorbid function. Two individuals in the
sample were strongly suspected to have early dementia, both of whom had elevated scores on the modified CDR
instruments. Among individuals rated as having no dementia based on the DSDS, about half showed subthreshold
impairments on the modified CDR instruments; there was substantial agreement between caregiver questionnaire
screening and in-person interview of caregivers and DS adults.
Conclusions: The modified questionnaire and interview instruments capture a range of impairment in DS adults,
including subthreshold symptomatology, and the instruments provide complementary information relevant to the
ascertainment of dementia in DS. Decline was seen across all cognitive domains and was generally positively related to
age and negatively related to IQ. Most importantly, adjusting instrument scores for chronic, premorbid impairment
drastically shifted the distribution toward lower (no impairment) scores.
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Background
Alzheimer disease (AD) is the most common cause of de-
mentia [1]. Because of the aging population worldwide,
AD is reaching epidemic proportions; in 2018, an esti-
mated 5.5 million United States citizens age 65 and older
had AD, which is projected to grow to 13.8 million by the
middle of this century if no effective therapies are devel-
oped to prevent, slow, or stop the disease [2]. Down
syndrome (DS) is the most commonly identified genetic
cause of cognitive impairment. Adults with DS have an in-
creased risk for developing AD dementia owing to the tri-
somy of chromosome 21 where the amyloid precursor
protein (APP) gene is located leading to overexpression of
both APP mRNA and amyloid beta (Aβ) peptide [3]. De-
mentia is often identified earlier in adults with DS com-
pared with the typical aging population, with estimates of
about 10% in DS adults in their 40s, about 30% in their
50s, and as high as 80% of DS adults in their 60s [3–5].
Cognitive and functional decline are the salient indica-
tors of AD [2, 6]. DS adults have pre-existing and varying
levels of intellectual disability and cognitive impairment
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[7] making it difficult to assess change relative to a typical
level of functioning. In the DS population, assessment of
change in cognitive function must take into account base-
line cognitive abilities [8, 9]. One of the first instruments
to be modified for use in DS was the Dementia Question-
naire for Persons with Mental Retardation (DMR [10, 11],
since renamed the Dementia Questionnaire for People
with Learning Disabilities (DLD)). Criticisms of the DMR/
DLD include lack of assessment of change from earlier
level of functioning, which results in significant floor ef-
fects, and use of different cutoff scores of increasing strin-
gency for higher levels of intellectual disability, the latter
of which is not always known or possible to assess [12–
14].
The Dementia Scale for Down Syndrome (DSDS) [15]
is an informant interview specifically for use in DS. It
contains a total of 60 items scored as present, absent,
typical of the individual, or not applicable; 20 items as-
sess early-stage dementia, 20 items assess middle stage
dementia, 15 items assess late-stage dementia, and 5
items assess very late-stage dementia [15]. The DSDS
was developed and standardized in a sample of adults
the majority of whom had severe to profound intellec-
tual disability; hence, the most common criticism is that
it may not be sensitive enough to detect dementia in
higher functioning individuals [16, 17]. A counterargu-
ment to this criticism is that informants may not be able
to detect early dementia-related changes in such individ-
uals [17].
The Cambridge Examination for Mental Disorders in
the Elderly (CAMDEX) [18] is an informant interview
developed for neuropsychiatric diagnosis in the elderly,
including dementia. It was modified for use in DS
(CAMDEX-DS) [19, 20]. The CAMDEX-DS consists of
approximately 150 questions that ask about functional
difficulties in different cognitive domains, whether such
difficulties represent a deterioration in function, and the
extent of the deterioration (slight or great) [20]. The
CAMDEX-DS has moderate to high inter-rater reliabil-
ity, good predictive validity, and correlates with change
in independent cognitive tasks administered to DS adults
longitudinally [19].
The Dementia Screening Questionnaire for Individuals
with Intellectual Disabilities (DSQIID [12]) was more re-
cently developed and is gaining wider use and popular-
ity. The DSQIID focuses specifically on change in
function relative to a premorbid level; it is brief and easy
to complete by a single informant. It has been translated
into multiple languages including Chinese [21] and Ital-
ian [13], and along with the original English version, all
versions have good psychometric properties [12, 13, 21].
In addition to these advances, it would be desirable to
adapt clinical staging instruments that are widely utilized
in scientific and clinical work involving AD dementia in
the broader population to afford comparability of assess-
ment and staging for scientific and clinical efforts involv-
ing individuals with DS. Therefore, we adapted the
Clinical Dementia Rating scale (CDR [22]) for use in DS.
The CDR is a semi-structured clinical diagnostic inter-
view that is an integral component of the Uniform Data
Set [23] that is used by all federally funded Alzheimer
Disease Centers (ADC) to determine the presence or ab-
sence of dementia for individuals being evaluated at
ADCs. The semi-structured interviews are administered
separately to an informant and then to the research par-
ticipant or patient and focus on capturing intra-
individual change from previous cognitive and functional
performance levels. An experienced clinician then syn-
thesizes the information from the interview to determine
the presence or absence of dementia and, when present,
its severity [22]. A CDR score of 0 indicates cognitive
normality, whereas scores of 0.5, 1, 2, and 3 indicate very
mild, mild, moderate, and severe dementia, respectively.
The primary goal of this project was to determine
whether adaptations of the CDR for DS—by both inter-
view and caregiver report—could reliably capture vari-
ation among DS patients when implementing new
adaptations of an established dementia rating scale.
Methods
Sample
In the first study phase, families with DS adults aged 18
years and older were recruited from the St. Louis ARC, a
non-profit organization that provides support and ser-
vices for individuals with intellectual and developmental
disabilities in the St. Louis region. Potential participants
were recruited via letters sent to the families by St. Louis
ARC. A total of 189 letters were sent asking families to
contact the study. Forty families (21.2% response rate)
contacted study staff over the telephone regarding their
interest to participate. Verbal consent was obtained from
the caregiver over the telephone and he/she was then
sent the questionnaire version of the modified CDR in-
strument (CDR-QDS) by postal mail. All forty CDR-
QDS instruments that were mailed were received back
for evaluation.
In the second study phase, families who completed the
CDR-QDS were subsequently invited to come to the la-
boratory. Families who agreed to participate after verbal
explanation over the telephone of this study phase were
sent the informed consent document to their homes
prior to their laboratory appointment. At the time of the
appointment, study staff went over study procedures, an-
swered any questions, and obtained signed informed
consent from the caregiver/legal guardian and signed as-
cent from the DS adult. A question as to whether the
DS adult knew why he/she is in the laboratory was asked
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to both the informant and the DS adult as part of the
interview process, to assess capacity.
The laboratory appointment involved administration
of (1) the modified interview format of the CDR (CDR-
IDS) to the informant and to the DS adult; (2) the De-
mentia Scale for Down Syndrome (DSDS) [15], for con-
vergent validity against which scores on the modified
CDR-QDS and CDR-IDS instruments were to be com-
pared. The DSDS informant interview is used as a
screening tool for dementia diagnosis in the multisite,
longitudinal Neurodegeneration in Aging Down Syn-
drome study (NiAD) [24, 25]. It has high inter-rater reli-
ability [15], moderate to high specificity and sensitivity
compared with clinical dementia diagnosis using DSM-
IV [26] or ICD-10 criteria [27], it correlates positively
with DMR scores [16, 28, 29] and is related to worse
memory task performance [29, 30] and lower scores on
information and orientation questions [30]; and (3) the
Raven’s Colored Progressive Matrices task [31] adminis-
tered to the DS adult to estimate intelligence quotient
(IQ). This task was chosen as a reasonable estimate of
IQ that would not be limited by speech impairment that
can be observed in DS adults.
Results from this study were not given to patient fam-
ilies. This study was approved by the Institutional Re-
view Board at Washington University in St. Louis.
Instrument modification
Questionnaire version: CDR-QDS
Original CDR questions were uniformly modified to as-
certain degree of cognitive impairment and the extent to
which change had occurred in relation to the partici-
pant’s prior baseline. In order to effect this general
modification, in some cases, we generated qualifiers for
affirmative responses; for example, endorsement of the
CDR question “Does he/she have problems with his/her
memory or thinking?” triggered a new follow-up ques-
tion: “Did he/she ALWAYS have a problem with his/her
memory or thinking?” (Yes (1)/No (0)). If the DS adult
was reported to currently have problems with memory
or thinking (current score = 1) but he/she always had
this problem (always score = 1), then the CDR-DS rating
for cognitive decline was calculated to be zero (current
score 1–always score 1 = 0).
In other cases, items related to the DS adult’s current
level of functioning were paired with identical companion
items eliciting an endorsement of the same item with re-
spect to his/her best ever level of functioning; for ex-
ample, the CDR question “How often does he/she know
the exact day of the month?” has response categories:
Usually (0), Sometimes (1), Rarely (2), and Don’t Know.
If the DS adult was reported to currently Rarely know
the exact day of the month but his/her best ever ability
was that he/she Sometimes knew the exact day of the
month, then the decline score would be 1 (current score
2–best ever score 1).
In still other cases, we changed response categories;
for example, the original CDR question “Rate his/her
ability to cope with small sums of money (e.g., calculate
change, leave a small tip)” has response categories: No
Loss (0), Some Loss (1), and Severe Loss (2). We
substituted No Loss with Never Able (0) and Some Abil-
ity/No Loss (0) response categories and kept Some Loss
(1) and Severe Loss (2). A difference (i.e., adjusted) score
could not be calculated for questions with these re-
sponse options since change relative to premorbid ability
was implicit in the response options.
CDR-QDS scores were generated for each of six func-
tional domains of the CDR—memory, judgment and
problem solving, orientation, community affairs, home
and hobbies, and personal care—by summing over re-
sponse categories of individual questions/items within
each domain. Higher scores reflected greater cognitive
decline. Cognitive domain scores were summed for a
total CDR-QDS summary score. Unlike the interview
instrument described below, we did not generate CDR-
QDS global scores because published rules for generat-
ing a global score [22] are based on interview data with
both an informant and the participant and include clin-
ical judgment garnered through direct observation and
personal interaction with the informant and patient.
Interview version: CDR-IDS
Examination of CDR-QDS data prompted modifications
that were included in the CDR-IDS. In addition, unlike
the CDR-QDS where a cognitive decline score was gener-
ated for every item, CDR-IDS scoring included clinical
judgment as well as direct assessment of the DS adult.
Two members of the team (CNLS and OLDR) underwent
CDR clinical training through the Knight Alzheimer Dis-
ease Research Center at Washington University. One
member (OLDR) performed the face-to-face interviews
with the informant and the DS adult and the other
reviewed the video recordings of the interviews. We each
scored the interviews separately and together reached a
consensus on disparate scores by discussing rationales for
the original scores. Consistent with CDR scoring [22],
each cognitive domain was given a score of 0 (typical), and
0.5, 1, 2, or 3 reflecting very mild, mild, moderate, or se-
vere dementia respectively. A sum of boxes CDR-IDS
score was generated by summing across cognitive domain
scores as well as a global CDR-IDS score generated using
published rules that weighted the memory domain score
more heavily than other domains [22]. The extended
number of modified questions in the CDR-IDS along with
the difference in the scoring process allowed us to gener-
ate scores that reflected no adjustment (i.e., current
scores) or adjustment for premorbid ability.
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Statistical analysis
Data were managed using REDCap electronic data
capture tools [32] hosted by the Washington Univer-
sity School of Medicine. REDCap (Research Electronic
Data Capture) is a secure, web-based application de-
signed to support data capture for research studies,
providing (1) an intuitive interface for validated data
entry; (2) audit trails for tracking data manipulation
and export procedures; (3) automated export proce-
dures for seamless data downloads to common statis-
tical packages; and (4) procedures for importing data
from external sources. Similarity in cognitive decline
scores across cognitive domains and across modified
questionnaire and interview instruments was esti-
mated using Spearman rank order correlation. Spear-
man correlation was also used to examine the
association of cognitive decline scores with age and
IQ. Inter-rater reliability in scoring of the modified




Of the 40 returned CDR-QDS questionnaires, 6 were
incomplete due to missing data. For the remaining 34
completed questionnaires (2 DS adults were nonver-
bal), mean age of the DS adults was 33.2 years old
(SD = 9.7; range 18–55 years), 15 were women
(44.1%), 30 DS adults lived with the responder
(88.2%), and the responder was the mother for 28 of
the DS adults (82.4%), with the father and full sibling
reporting on 4 and 2 of the DS adults, respectively
(11.8% and 5.9%). Respondents reported spending an
average of 55.5 h per week with the DS adult (SD =
29.5, range 4–112 h).
Thirty-three of the 34 families with CDR-QDS data
were invited to come to the laboratory. From these 33
families, 22 completed assessments in the laboratory.
Of the 11 families who did not come to the laboratory,
5 declined to participate, 4 withdrew from the study
after initially agreeing to participate, and 2 families did
not respond to repeated calls. Five of the 9 families
who declined to participate or withdrew from the study
had reported relatively high CDR-QDS scores for the
DS adult (≥ 14 where the scoring range was 0–32). The
22 participant families comprised 10 women with DS
(45.5%), all non-Hispanic White, of average age 32.8
(SD = 8.9, range 20–56 years) and average IQ of 59 (SD
= 19.5, range 24–85; IQ was not computed for two in-
dividuals who were not able to complete Raven’s task,
one of whom was nonverbal).
History of medical and behavioral problems was ob-
tained from the differential diagnosis screening ques-
tions of the DSDS [15]. Of the 22 DS adults, 16 (72.7%)
had hypothyroidism; 9 (40.9%) had hearing/ear prob-
lems; 5 (22.7%) had vision problems; 5 had heart prob-
lems; 6 (27.3%) had sleep apnea; 5 had depression,
anxiety, or mood problems; 2 (9.1%) had suicidal idea-
tion; 11 (50%) had obsessive-compulsive disorder; and 2
had aggressive behavior including verbal aggression.
There was 80% power to detect a correlation coeffi-
cient ≥ |0.44| (2-tailed alpha) with n = 34 and a coeffi-
cient ≥ |0.53| (2-tailed alpha) with n = 22.
CDR-IDS inter-rater reliability
Table 1 shows that inter-rater reliability was very high
for CDR-IDS cognitive domain and global scores ad-
justed for premorbid function (kappas = 0.82 to 1).
Inter-rater reliability was overall high for unadjusted
CDR-IDS scores (kappas = 0.79 to 1) with the weak-
est reliability (kappa = 0.55) for the judgment and
problem solving cognitive domain.
Distribution of CDR-QDS and CDR-IDS scores
Figure 1 shows the distribution of summary CDR-
QDS scores (n = 34); the sample manifested a wide
range of scores. The distribution was skewed toward
lower scores where 13 individuals had a score of 0
(38.2%), and another 10 individuals had scores of 1
or 2 (29.4%). CDR-QDS summary score mean was
4.85 (SD = 7.29, median = 1, range 0–23, maximum
possible score = 32). There were three individuals
with CDR-QDS scores ≥ 20, all of whom were over
the age of 30 years.
Figure 2 shows the distribution of CDR-IDS sum
of boxes (upper panel), global (middle panel), and
dichotomized global scores (lower panel) (n = 22)
when scores were adjusted for premorbid function
(adjusted) and not adjusted (unadjusted), which
would be consistent with current function. As pre-
dicted, adjusting for premorbid ability shifted, in the
non-pathological direction, scores that would other-
wise be elevated on the standard version of the
Table 1 Inter-rater reliability for CDR-IDS scores before
(unadjusted) and after (adjusted) accounting for premorbid
function
CDR-IDS domain and global
scores n = 22
Unadjusted Adjusted
Kappa SE Kappa SE
Memory 0.79 0.11 0.91 0.08
Orientation 0.94 0.06 1.00 0.00
Judgment and problem solving 0.55 0.13 0.82 0.15
Community affairs 0.92 0.08 1.00 0.00
Home and hobbies 1.00 0.00 1.00 0.00
Personal care 0.86 0.09 1.00 0.00
CDR-IDS global score 0.92 0.08 0.92 0.08
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CDR. CDR-IDS adjusted sum of boxes sample mean
was 1.68 (SD = 3.90, median = 0.5, range 0–16,
maximum possible score = 18) and unadjusted mean
was 4.41 (SD = 3.88, median = 3, range 0.5–16). The
table embedded in the middle panel of Fig. 2 shows the
extent to which adjustment for premorbid ability shifted
individuals to lower global CDR-IDS scores. For example,
of the 13 DS adults with adjusted global CDR-IDS scores
of 0, 10 had unadjusted scores of 0.5. The shift from any
severity of dementia (CDR-IDS > 0) to no dementia
(CDR-IDS = 0) is most pronounced in the lower panel,
where nearly the entire sample (21 of 22 DS adults) meets
criteria for at least very mild dementia before score adjust-
ment, but only 9 individuals meet the dichotomized de-
mentia threshold after score adjustment.
Relationship of age and IQ to CDR-QDS and CDR-IDS
Table 2 shows that older age was significantly re-
lated to greater decline in all CDR-QDS cognitive
domains, except for memory and total score. When
individuals with zero scores were excluded from cor-
relation estimation, older age was significantly re-
lated to both memory decline (Spearman rho = 0.49,
p < 0.05, n = 17) and to total CDR-QDS score (rho
= 0.41, p < 0.05, n = 21).
Older age was not significantly related to CDR-IDS
domain, sum of boxes, or global decline scores. Ex-
cluding individuals with zero scores resulted in stron-
ger relationships between older age and decline in
memory (rho = 0.62, p = 0.14, n = 7), home and hob-
bies (rho = 0.50, p = 0.31, n = 6), CDR-IDS sum of
boxes (rho = 0.32, p = 0.31, n = 12), and CDR-IDS
global score (rho = 0.83, p < 0.05, n = 9). The sample
size was n = 2 to 4 for the remaining four domains.
Higher IQ was related to lower (better) cognitive
function scores overall for both the CDR-QDS and
CDR-IDS instruments with correlations (rho > − 0.45)
reaching statistical significance.
Relationship between CDR-QDS, CDR-IDS, and DSDS
Table 3 shows that decline in any one domain was sig-
nificantly associated with decline in other domains and
in summary scores within instrument (upper two panels)
and across instruments (lower panel). The strongest re-
lationship between the CDR-QDS and CDR-IDS was in
the domain for personal care (rho = 0.87) and the weak-
est relationship was for judgment and decision-making
(rho = 0.44) and orientation (rho = 0.45). There was a
high correspondence between the CDR-QDS summary
score and the CDR-IDS sum of boxes score (rho = 0.69).
DSDS ratings resulted in 20 of 22 individuals having
no dementia (data not shown). One person had a DSDS
cognitive cutoff score of 2, a threshold for which 6-
month reassessment is recommended [15]. One person
had a DSDS rating consistent with early dementia (cog-
nitive cutoff score ≥ 3 and total early and middle stage
items present ≥ 10 but < 17). These two DS adults had,
respectively, high summary CDR-QDS scores of 17 and
10, high CDR-IDS sum of boxes of 10.5 and 16, and the
two highest global CDR-IDS scores of 2 and 3. Among
the 20 DS adults rated as having no dementia according
to the DSDS, 8 individuals had non-zero CDR-QDS
scores (range 1–8) and 7 individuals had non-zero ad-
justed CDR-IDS global scores (0.5 and 1).
Discussion
The modified CDR-QDS and CDR-IDS instruments cap-
tured a range of cognitive decline, provided complementary
Fig. 1 Frequency distribution of summary scores of the CDR questionnaire for Down syndrome (CDR-QDS)
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information and exhibited moderate to strong inter-
correlations for the critical domains.
Our approach to account for premorbid function is
similar to that of the CAMDEX-DS interview and
DSQIID questionnaire. In the CAMDEX-DS, endorse-
ment of functional difficulty is followed by a question of
whether the difficulties represent deterioration [20]. In
the DSQIID, accounting for premorbid function is impli-
cit in the response options of individual items, which in-
clude the following: always been the case, always but
worse, new symptom in past year, and does not apply
[12]. The recommended cutoff score for the DSQIID is
Fig. 2 Frequency distributions of the CDR interview for Down syndrome (CDR-IDS) sum of boxes (upper panel), global scores (middle panel), and
dichotomized global scores (lower panel). Score distributions are shown before and after adjustment for premorbid ability. The table embedded
in the middle panel illustrates the shift of individuals from higher unadjusted to lower adjusted global scores
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≥ 20 for best sensitivity and specificity of the English
version [12], and ≥ 22 for the Chinese version [21]. It
was not possible to establish cutoff scores for the CDR-
QDS because of our limited sample size.
In our study, accounting for premorbid abilities dra-
matically shifted the score distribution toward lower (no
dementia) scores, which clearly demonstrates how not
accounting for premorbid abilities would result in a high
false positive rate of cognitive impairment. CDR scoring
for the typical population emphasizes memory domain
scores [22]. This emphasis was not uniformly seen in
our sample. For example, unadjusted CDR-IDS scores
showed that of 8 DS adults whose unadjusted memory
domain scores were zero, 6 individuals had scores on
Table 2 Spearman correlations of cognitive domains and summary scores with age and IQ
Domains and summary scores CDR-QDS (n = 34) CDR-IDS (n = 22)
Age IQ (n = 20) Age IQ (n = 20)
Memory 0.11 − 0.35 0.21 − 0.32
Orientation 0.37 − 0.47 0.13 − 0.27
Judgment and problem solving 0.40 − 0.42 0.31 − 0.36
Community affairs 0.35 − 0.62 0.38 − 0.30
Home and hobbies 0.36 − 0.49 0.13 − 0.41
Personal care 0.37 − 0.49 0.39 − 0.54
CDR-QDS summary/CDR-IDS sum of boxes 0.11 − 0.45 0.16 − 0.52
CDR-IDS global score n/a 0.10 − 0.46
Statistically significant correlations (p < 0.05) are in italics
Table 3 Spearman correlations across cognitive domains and summary scores within and between instruments
CDR-QDS (n = 34) Memory Orientation Judgment Community affairs Home and hobbies Personal care Summary score
Orientation 0.68
Judgment and problem solving 0.69 0.85
Community affairs 0.65 0.80 0.87
Home and hobbies 0.65 0.62 0.85 0.81
Personal care 0.69 0.68 0.90 0.87 1.00
Summary score 0.91 0.70 0.81 0.80 0.75 0.77
CDR-IDS (n = 22) Memory Orientation Judgment Community affairs Home and hobbies Personal care Sum of boxes
Orientation 0.45
Judgment and problem solving 0.54 0.59
Community affairs 0.60 0.84 0.74
Home and hobbies 0.43 0.48 0.39 0.64
Personal care 0.58 0.59 0.50 0.74 0.62
Sum of boxes 0.77 0.50 0.57 0.53 0.71 0.70
Global score 0.87 0.60 0.48 0.57 0.47 0.72 0.87
CDR-IDS CDR-QDS
Memory Orientation Judgment Community affairs Home and hobbies Personal care Summary score
Memory 0.66 0.62 0.48 0.60 0.45 0.43 0.51
Orientation 0.70 0.45 0.53 0.48 0.68 0.66 0.60
Judgment and problem solving 0.53 0.35 0.44 0.40 0.59 0.57 0.41
Community affairs 0.60 0.65 0.68 0.63 0.83 0.81 0.54
Home and hobbies 0.42 0.66 0.92 0.73 0.75 0.74 0.66
Personal care 0.52 0.35 0.66 0.63 0.87 0.87 0.63
Sum of boxes 0.61 0.51 0.69 0.54 0.61 0.61 0.69
Global score 0.69 0.48 0.53 0.51 0.60 0.59 0.66
Statistically significant correlations (p < 0.05) are in italics
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other domains that suggested mild to severe dementia.
CDR-IDS unadjusted scores across domains could in-
clude the entire scoring range from zero (no dementia)
to three (severe dementia) for an individual. Such dis-
crepancy in score magnitude across cognitive domains is
not seen in typical aging adults (Dr. John Morris, per-
sonal communication, March 2018), and underscores
both the wide individual variability in cognitive function
in DS adults [34] and the importance of accounting for
premorbid ability in dementia assessment. Adjusted
CDR-IDS domain scores did not differ by more than one
scoring category for any individual. It has been suggested
that memory impairment may not be an early behavioral
indicator of dementia in the DS population, rather emo-
tional and behavioral problems (e.g., apathy, increased
irritability, increased aggression, decreased interest in so-
cial interaction) and executive dysfunction (e.g., atten-
tion, planning) may be earlier symptoms of dementia in
the DS population [12, 35–37], although these must be
differentiated from treatable neuropsychiatric comorbid-
ities in clinical practice. It has also been argued that
memory problems have a similar time course of deteri-
oration in DS as in the typical aging population. Admin-
istration of a cognitive battery to nearly 300 DS
individuals aged 16 years and older showed that changes
in performance in visuospatial associate memory, hand-
eye coordination, and semantic verbal fluency preceded
other cognitive changes, implicating these cognitive do-
mains as early, prodromal behavioral markers of cogni-
tive deterioration in DS [38]. In addition, change in tasks
directly administered to DS individuals was seen earl-
ier than change based on informant report, suggesting
that the latter may not be sufficiently sensitive to de-
tect early cognitive decline [38]. Similarly, the modi-
fied CDR-QDS and CDR-IDS instruments, entirely or
mostly informant-based, may not be sensitive to de-
tect subtle, early changes of cognitive decline, includ-
ing memory problems.
Higher IQ was related to lower levels of cognitive de-
cline. In the typically developing aging population,
greater “cognitive reserve,” a measure that combines IQ,
education, and lifelong engagement in cognitive activities
[39], is also related to lower cognitive decline [40]. Here,
we show a relationship in the lower distribution of IQ
scores assessed using a single task.
Inclusion of the DSDS was meant to serve as an external
validity index, but our sample did not reveal sufficient vari-
ability in DSDS scoring, and it is notable that a wider range
of scores were elicited among the subjects using the CDR in-
struments. The vast majority of the sample was rated as hav-
ing no dementia on the DSDS, but most had non-zero CDR-
QDS and CDR-IDS scores; the 2 individuals flagged for re-
assessment or rated as early dementia on the DSDS had
higher CDR-QDS scores, as well as CDR-IDS adjusted global
scores consistent with moderate and severe dementia. The
DSDS was developed and validated in a community sample
of individuals the majority of whom had severe to profound
intellectual disability which could result in low sensitivity of
the DSDS in detecting dementia in higher functioning indi-
viduals [16, 17]. We note that in another instrument, the
DSQIID, has been adapted by the National Task Group
(NTG) on Intellectual Disabilities and Dementia Practices as
an Early Detection Screen for Dementia (NTG-EDSD [41]),
for wide use in dementia screening. Our results using com-
parable methods in the questionnaire version of the CDR
support the utility of questionnaire-based screening, and fu-
ture studies should continue to explore the utility of combin-
ing caregiver screening and direct observation in identifying
dementia in DS and distinguishing it from other neuro-
psychiatric impairments that can result in cognitive decline
in DS, most notably, catatonia, which is rare and controver-
sial, but is treatable [42] and may assist clinicians in avoiding
a false designation of dementia on the basis of observations
or ratings that suggest cognitive decline, especially in younger
adults with DS.
The participant interview portion of the CDR-IDS was
difficult to administer to DS adults who were nonverbal
or whose speech was limited or difficult to understand.
The original CDR was developed for the typical popula-
tion and in more extreme cases, it cannot capture the
full range of disability. Ability to capture cognitive de-
cline across the range of premorbid impairment in DS
individuals, from low to high functioning, with a single
instrument is a challenge [43]. In the CDR, “thinking
and memory problems” are considered interchangeably,
but caregiver informants regarded “thinking” and “mem-
ory” to be different phenomena and were often unsure
how to answer questions that asked about thinking and
memory problems together. Some spatial orientation
questions were difficult because DS participants in our
study were never alone and informants could not evalu-
ate whether the DS adult would be able to find his/her
way around familiar streets, for example. Ability to man-
age a household emergency like a small leak or fire did
not seem applicable in our sample, again, since DS
adults were almost never alone—even those who live in-
dependently have scheduled visitors and structured days.
Ability to drive a vehicle or do calculations was absent
in our entire sample.
Based on our data and on personal interaction with
DS adults and their family members, ongoing research
should continue to focus on elements of caregiver report
and direct assessment of the DS individual that will
optimize differential diagnosis. The primary goal of this
study was to adapt the widely used CDR for assessment
of dementia in adults with DS. We have shown that such
adaptation was successful in capturing a range of cogni-
tive decline and in shifting the distribution of decline
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scores toward lower/no impairment by adjusting original
CDR questions to take into account premorbid intellec-
tual and functional ability. Future work of the CDR-QDS
and CDR-IDS should include comparison with existing
instruments such as the CAMDEX-DS and DSQIID,
with neuropsychological performance, and with other
biomarkers, such as positron emission tomography for
amyloid or tau.
Conclusions
The modified CDR questionnaire (CDR-QDS) and inter-
view (CDR-IDS) instruments capture a range of impair-
ment in DS adults. Adjustment of cognitive decline
scores for premorbid function dramatically shifted the
score distribution toward no/low impairment and was
an important element in identifying DS adults with sus-
picion for dementia. The DSDS indicated high suspicion
of dementia in two of twenty-two individuals in this
sample who had broadly elevated scores on the modified
CDR instruments. The modified CDR instruments cap-
tured a range of subthreshold impairments in cognitive
function that may prove extremely useful in prospective
studies of the development of AD in DS. Moreover, fu-
ture research is warranted to use quantitative scales such
as these to help differentiate dementia from other neuro-
psychiatric problems in DS, including catatonia, adjust-
ment disorder, and a range of psychiatric comorbidities,
all of which are potentially treatable and for which in-
appropriate/premature assignment of a diagnosis of de-
mentia may be extremely misleading and result in a
major obstacle to appropriate care and treatment. For
DS adults with elevated scores for cognitive impairment
in this study, the impairment generally encompassed
multiple cognitive domains and was not predominantly
within the memory domain, as seen in the typical
population.
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